Clinical Trials
4 trialsNCT00285259 2024-10-21
Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Astellas Pharma Inc
Phase 2 Completed
NCT05305040 2024-05-16
Prevent
AlloVir
Phase 2/3 Terminated
NCT04693637 2024-05-09
Prevent
AlloVir
Phase 2/3 Completed
NCT02108522 2021-07-20
CHARMS
AlloVir
Phase NA Completed